Stay updated on Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Sign up to get notified when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the usual study content with an access-restricted notice and minimal navigation.
    Difference
    20%
    Check dated 2026-09-21T22:17:54.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the study page, signaling a new version of the document. This represents an update or correction to the page content reflected by the new revision number.
    Difference
    0.0%
    Check dated 2026-08-31T17:12:50.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.6.5 updated from v3.6.4, signaling a software update to the page. This change does not appear to modify the study content or displayed information.
    Difference
    0.0%
    Check dated 2026-08-10T11:51:22.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a new internal revision. This appears to be maintenance-only and does not reflect changes to the study information or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-27T06:17:44.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    The page revision label has been updated to v3.6.3, indicating a new version of the page. This reflects a small administrative update to the page without changing the study details.
    Difference
    0.0%
    Check dated 2026-07-05T13:27:39.000Z thumbnail image

Stay in the know with updates to Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imprime PGG+Pembrolizumab in Melanoma & TNBC Clinical Trial page.